Literature DB >> 12393411

Exogenous stress proteins enhance the immunogenicity of apoptotic tumor cells and stimulate antitumor immunity.

Hanping Feng1, Yi Zeng, Michael W Graner, Anna Likhacheva, Emmanuel Katsanis.   

Abstract

We have previously reported that apoptotic tumor cells can be either immunogenic or nonimmunogenic in vivo, depending on whether or not these cells are heat stressed before induction of apoptosis. Stressed apoptotic cells express heat shock proteins on their plasma membranes and dendritic cells are capable of distinguishing them from nonstressed apoptotic cells. Here we provide evidence that when purified heat shock protein 70 or chaperone-rich cell lysate (CRCL) from syngeneic normal tissue is used as an adjuvant with nonimmunogenic apoptotic tumor cells in vaccination, potent antitumor immunity can be generated. This antitumor immunity is mediated by T cells because antitumor effects are not observed in either severe combined immunodeficiency or T cell-depleted mice. We further demonstrate that vaccination of mice with apoptotic tumor cells mixed with liver-derived CRCL as adjuvant were capable of enhancing the production of T(H)1 cytokines, inducing specific cytotoxic T lymphocytes and eliciting long-lasting antitumor immunity. Stress proteins from autologous normal tissue components therefore can serve as danger signals to enhance the immunogenicity of apoptotic tumor cells and stimulate tumor-specific immunity

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393411     DOI: 10.1182/blood-2002-05-1580

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  30 in total

1.  Apoptosis is essential for the increased efficacy of alphaviral replicase-based DNA vaccines.

Authors:  Wolfgang W Leitner; Leroy N Hwang; Elke S Bergmann-Leitner; Steven E Finkelstein; Stephan Frank; Nicholas P Restifo
Journal:  Vaccine       Date:  2004-03-29       Impact factor: 3.641

2.  Severe, but not mild heat-shock treatment induces immunogenic cell death in cancer cells.

Authors:  Irena Adkins; Lenka Sadilkova; Nada Hradilova; Jakub Tomala; Marek Kovar; Radek Spisek
Journal:  Oncoimmunology       Date:  2017-03-31       Impact factor: 8.110

Review 3.  How dying cells alert the immune system to danger.

Authors:  Hajime Kono; Kenneth L Rock
Journal:  Nat Rev Immunol       Date:  2008-03-14       Impact factor: 53.106

4.  Chemokine programming dendritic cell antigen response: part I - select chemokine programming of antigen uptake even after maturation.

Authors:  Jaehyung Park; Cindy T Wu; James D Bryers
Journal:  Immunology       Date:  2013-05       Impact factor: 7.397

5.  Clostridium difficile toxin B intoxicated mouse colonic epithelial CT26 cells stimulate the activation of dendritic cells.

Authors:  Tuxiong Huang; Gregorio Perez-Cordon; Lianfa Shi; Guangchao Li; Xingmin Sun; Xiaoning Wang; Jufang Wang; Hanping Feng
Journal:  Pathog Dis       Date:  2015-01-27       Impact factor: 3.166

6.  Chemokine programming dendritic cell antigen response: part II - programming antigen presentation to T lymphocytes by partially maintaining immature dendritic cell phenotype.

Authors:  Jaehyung Park; James D Bryers
Journal:  Immunology       Date:  2013-05       Impact factor: 7.397

Review 7.  Sterile inflammation in the liver and pancreas.

Authors:  Rafaz Hoque; Ahmad Farooq; Wajahat Z Mehal
Journal:  J Gastroenterol Hepatol       Date:  2013-08       Impact factor: 4.029

8.  Antitumor immunity induced by DNA vaccine encoding alpha-fetoprotein/heat shock protein 70.

Authors:  Xiao-Ping Wang; Guo-Zhen Liu; Ai-Li Song; Hai-Yan Li; Yu Liu
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

Review 9.  Facets of heat shock protein 70 show immunotherapeutic potential.

Authors:  Stephen M Todryk; Michael J Gough; A Graham Pockley
Journal:  Immunology       Date:  2003-09       Impact factor: 7.397

10.  Induction of BCR-ABL-specific immunity following vaccination with chaperone-rich cell lysates derived from BCR-ABL+ tumor cells.

Authors:  Yi Zeng; Michael W Graner; Sylvia Thompson; Marilyn Marron; Emmanuel Katsanis
Journal:  Blood       Date:  2004-09-16       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.